Frank Vinluan

Latest from Frank Vinluan

Roche enlists Dyno to bring AI to liver, CNS gene therapies
Deal-Making
Roche enlists Dyno to bring AI to liver, CNS gene therapiesRoche enlists Dyno to bring AI to liver, CNS gene therapies
byFrank Vinluan
Oct 20, 2020
5 Min Read
SQZ Biotech lines up $75m IPO for cell therapy R&D
Regulations
SQZ Biotech lines up $75m IPO for cell therapy R&DSQZ Biotech lines up $75m IPO for cell therapy R&D
byFrank Vinluan
Oct 14, 2020
4 Min Read

All from Frank Vinluan

BMS to buy MyoKardia, adding heart disease drug for $13.1bn
Deal-Making
BMS to buy MyoKardia, adding heart disease drug for $13.1bn
BMS to buy MyoKardia, adding heart disease drug for $13.1bn
Oct 5, 2020
|
4 Min Read
byFrank Vinluan
Lumen Bioscience lands $16m to engineer “edible” antibody drugs
Therapeutic Class
Lumen Bioscience lands $16m to engineer “edible” antibody drugs
Lumen Bioscience lands $16m to engineer “edible” antibody drugs
Sep 14, 2020
|
6 Min Read
byFrank Vinluan
Gilead adds ‘cornerstone’ cancer drug in $21bn Immunomedics buyout
Deal-Making
Gilead adds ‘cornerstone’ cancer drug in $21bn Immunomedics buyout
Gilead adds ‘cornerstone’ cancer drug in $21bn Immunomedics buyout
Sep 14, 2020
|
3 Min Read
byFrank Vinluan
CureVac’s IPO hauls in $213m as mRNA COVID-19 vaccine test nears
Therapeutic Class
CureVac’s IPO hauls in $213m as mRNA COVID-19 vaccine test nears
CureVac’s IPO hauls in $213m as mRNA COVID-19 vaccine test nears
Aug 20, 2020
|
5 Min Read
byFrank Vinluan
J&J boosts autoimmune disease pipeline with $6.5bn Momenta buy
Deal-Making
J&J boosts autoimmune disease pipeline with $6.5bn Momenta buy
J&J boosts autoimmune disease pipeline with $6.5bn Momenta buy
Aug 19, 2020
|
5 Min Read
byFrank Vinluan
Forge Bio’s combo model for gene therapies attracts $40m in funding
Deal-Making
Forge Bio’s combo model for gene therapies attracts $40m in funding
Forge Bio’s combo model for gene therapies attracts $40m in funding
Jul 23, 2020
|
5 Min Read
byFrank Vinluan
AveXis ‘flexible’ NC plant a step closer to fully internal gene therapy network
Facilities & Capacity
AveXis ‘flexible’ NC plant a step closer to fully internal gene therapy network
AveXis ‘flexible’ NC plant a step closer to fully internal gene therapy network
Feb 24, 2020
|
4 Min Read
byDan Stanton, Frank Vinluan

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Ask the Expert webcasts
ATE Webcasts
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe